215 related articles for article (PubMed ID: 31405787)
21. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes.
Shah A; Craner J; Cunningham JL
J Subst Abuse Treat; 2017 Jun; 77():95-100. PubMed ID: 28476279
[TBL] [Abstract][Full Text] [Related]
22. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
Shi Y; Cao Y; Shang C; Pacula RL
Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
[TBL] [Abstract][Full Text] [Related]
23. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy.
Lo SY; Winston-McPherson GN; Starosta AJ; Sullivan MD; Baird GS; Hoofnagle AN; Greene DN
Am J Med; 2019 Mar; 132(3):347-353. PubMed ID: 30419224
[TBL] [Abstract][Full Text] [Related]
24. Pain-related anxiety and opioid misuse in a racially/ethnically diverse young adult sample with moderate/severe pain.
Rogers AH; Bakhshaie J; Lam H; Langdon KJ; Ditre JW; Zvolensky MJ
Cogn Behav Ther; 2018 Sep; 47(5):372-382. PubMed ID: 29482460
[TBL] [Abstract][Full Text] [Related]
25. BMI influences relationships among health factors for adults with persistent pain who use prescription opioids.
Bigand T; Bindler R; James L; Daratha K; Wilson M
Nurs Outlook; 2020; 68(4):440-448. PubMed ID: 32402394
[TBL] [Abstract][Full Text] [Related]
26. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use and schizotypy: the role of social anxiety and other negative affective states.
Najolia GM; Buckner JD; Cohen AS
Psychiatry Res; 2012 Dec; 200(2-3):660-8. PubMed ID: 22920791
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Correlates of Low Pain Interference Among Patients With High Pain Intensity Who Are Prescribed Long-Term Opioid Therapy.
Adams MH; Dobscha SK; Smith NX; Yarborough BJ; Deyo RA; Morasco BJ
J Pain; 2018 Sep; 19(9):1074-1081. PubMed ID: 29705347
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.
Zhang C; Slawek DE; Ross J; Zolotov Y; Castillo F; Levin FR; Sohler NL; Minami H; Cunningham CO; Starrels JL; Arnsten JH
Cannabis Cannabinoid Res; 2024 Jun; 9(3):e859-e869. PubMed ID: 36961410
[No Abstract] [Full Text] [Related]
30. Tapentadol prolonged release and the long-term management of chronic musculoskeletal pain in the elderly - focus on anxiety, depression, cognitive status and life quality: the TaPE study.
Tarsitano A; Cortese M; Barile M; Scarpelli P
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(4 Suppl):35-39. PubMed ID: 31755081
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use.
Kalaba M; Ware MA
Cannabis Cannabinoid Res; 2022 Dec; 7(6):840-851. PubMed ID: 33999649
[No Abstract] [Full Text] [Related]
32. Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients.
McCrabb S; Baker AL; Attia J; Balogh ZJ; Lott N; Palazzi K; Naylor J; Harris IA; Doran CM; George J; Wolfenden L; Skelton E; Bonevski B
BMC Psychiatry; 2019 Jan; 19(1):28. PubMed ID: 30654783
[TBL] [Abstract][Full Text] [Related]
33. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ
J Pain; 2020; 21(5-6):570-581. PubMed ID: 31560957
[TBL] [Abstract][Full Text] [Related]
34. Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.
Cunningham CO; Starrels JL; Zhang C; Bachhuber MA; Sohler NL; Levin FR; Minami H; Slawek DE; Arnsten JH
BMJ Open; 2020 Dec; 10(12):e043400. PubMed ID: 33376181
[TBL] [Abstract][Full Text] [Related]
35. Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ
J Pain; 2019 Jul; 20(7):830-841. PubMed ID: 30690169
[TBL] [Abstract][Full Text] [Related]
36. A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.
Arkell TR; Manning B; Downey LA; Hayley AC
CNS Drugs; 2023 Nov; 37(11):981-992. PubMed ID: 37945917
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.
Rapin L; Gamaoun R; El Hage C; Arboleda MF; Prosk E
J Cannabis Res; 2021 Jun; 3(1):19. PubMed ID: 34162446
[TBL] [Abstract][Full Text] [Related]
38. Cannabis use expectancies mediate the relation between depressive symptoms and cannabis use among cannabis-dependent veterans.
Farris SG; Zvolensky MJ; Boden MT; Bonn-Miller MO
J Addict Med; 2014; 8(2):130-6. PubMed ID: 24365805
[TBL] [Abstract][Full Text] [Related]
39. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.
Kvamme SL; Pedersen MM; Rømer Thomsen K; Thylstrup B
Harm Reduct J; 2021 Jul; 18(1):72. PubMed ID: 34246279
[TBL] [Abstract][Full Text] [Related]
40. Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation.
Rogers AH; Orr MF; Shepherd JM; Bakhshaie J; Ditre JW; Buckner JD; Zvolensky MJ
J Behav Med; 2021 Feb; 44(1):66-73. PubMed ID: 32594288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
